SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-096651
Filing Date
2022-08-31
Accepted
2022-08-31 20:11:12
Documents
2
Period of Report
2022-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2224852-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2224852-1_3seq1.xml 3 1613
2 EXHIBIT 24 tm2224852d1_ex24.htm EX-24 5934
  Complete submission text file 0001104659-22-096651.txt   8985
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORGANOGENESIS INC., 85 DAN ROAD CANTON MA 02021
Business Address
Hagopian Henry III (Reporting) CIK: 0001821822 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39202 | Film No.: 221219267